Generic Name and Formulations:
Dexamethasone 0.1%; oph susp; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for MAXIDEX:
Adults and Children:
Instill 1–2 drops in the affected eye(s). Severe: may administer hourly, then taper as condition improves. Mild: may administer up to 4–6 times daily.
Acute, untreated bacterial, fungal, mycobacterial, epithelial herpes simplex, or viral (except herpes zoster) infections of the eye.
Corneal or scleral thinning. Glaucoma. Monitor for secondary infections and intraocular pressure if used for ≥10 days. Avoid abrupt cessation. Pregnancy. Nursing mothers.
Local irritation, ocular discomfort, increased intraocular pressure, cataracts, corneal perforations, optic nerve damage; may mask or exacerbate infections.
Endocrinology Advisor Articles
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- Clinicians May Be Overtreating Older Patients With Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Hormonal Contraceptives May Adversely Affect Psychological Health in Adolescent Girls
- Obesity Can Negatively Effect Liver in Children as Young as 8
- Recommendations Developed on Gender Equity in Medicine